Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.680
+0.060 (3.70%)
At close: Dec 20, 2024, 4:00 PM
1.640
-0.040 (-2.38%)
After-hours: Dec 20, 2024, 5:27 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $31.68 million as of December 20, 2024. Its market cap has increased by 458.20% in one year.
Market Cap
31.68M
Enterprise Value
12.64M
1-Year Change
458.20%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $31.68M, a decrease of -94.98%. That is a compound annual growth rate of -54.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 31.68M | 425.47% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 32.02M |
| Tempest Therapeutics | 31.84M |
| Beyond Air | 31.03M |
| Nortech Systems | 30.15M |
| Accelerate Diagnostics | 30.05M |
| Intensity Therapeutics | 29.74M |
| OneMedNet | 29.67M |
| RAPT Therapeutics | 29.08M |